ALPHAHELIX MOL.DIAGN. SK1 (4MB) - Cash Flow Conversion Efficiency

Latest as of December 2025: 1.857x

Based on the latest financial reports, ALPHAHELIX MOL.DIAGN. SK1 (4MB) has a cash flow conversion efficiency ratio of 1.857x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€1.18 Million ≈ $1.38 Million USD) by net assets (€637.00K ≈ $744.72K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

ALPHAHELIX MOL.DIAGN. SK1 - Cash Flow Conversion Efficiency Trend (2022–2025)

This chart illustrates how ALPHAHELIX MOL.DIAGN. SK1's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read 4MB total debt and obligations for a breakdown of total debt and financial obligations.

ALPHAHELIX MOL.DIAGN. SK1 Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of ALPHAHELIX MOL.DIAGN. SK1 ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Sobr Safe Inc
NASDAQ:SOBR
-0.338x
Montanaro UK Smaller Companies Investment Trust PLC
LSE:MTU
-0.009x
Eurotex Industries and Exports Limited
NSE:EUROTEXIND
0.047x
Pathfinder Ventures Inc
V:RV
0.233x
Digjam Limited
NSE:DIGJAMLTD
-0.688x
Global Energy Metals Corp
V:GEMC
-0.011x
Sienna Resources Inc
V:SIE
-0.071x
Gossan Resources Ltd
V:GSS
-0.341x

Annual Cash Flow Conversion Efficiency for ALPHAHELIX MOL.DIAGN. SK1 (2022–2025)

The table below shows the annual cash flow conversion efficiency of ALPHAHELIX MOL.DIAGN. SK1 from 2022 to 2025. For the full company profile with market capitalisation and key ratios, see ALPHAHELIX MOL.DIAGN. SK1 stock valuation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 €637.00K
≈ $744.72K
€820.00K
≈ $958.67K
1.287x +219.69%
2024-12-31 €4.18 Million
≈ $4.88 Million
€-4.49 Million
≈ $-5.25 Million
-1.076x -105.67%
2023-12-31 €10.41 Million
≈ $12.18 Million
€-5.45 Million
≈ $-6.37 Million
-0.523x -462.81%
2022-12-31 €19.89 Million
≈ $23.25 Million
€2.87 Million
≈ $3.35 Million
0.144x --

About ALPHAHELIX MOL.DIAGN. SK1

F:4MB Germany Diagnostics & Research
Market Cap
$1.68 Million
€1.44 Million EUR
Market Cap Rank
#29946 Global
#2632 in Germany
Share Price
€0.02
Change (1 day)
+0.00%
52-Week Range
€0.01 - €0.03
All Time High
€0.32
About

Level Bio AB (publ) manufactures and distributes cutting-edge and diagnostic solutions in the Nordic region and internationally. It develops and manufactures diagnostic kits for the clinical market, as well as act as a distributor and full service partner to molecular biology labs in the Nordics. The company was formerly known as AlphaHelix Molecular Diagnostics AB (publ) and changed its name to … Read more